BioSpace News Archive

Dental Laboratories Market Size to Hit Around US$ 53.3 Bn by 2030

The global Dental Laboratories market size is expected to be worth around US$ 53.3 billion by 2030, according to a new report by Vision Research Reports.

April 27, 2022
·
4 min read
Artificial Intelligence in Diagnostics Market Size to Surpass US$ 10.8 Bn by 2030

The global Artificial Intelligence in Diagnostics market size is expected to surpass around US$ 10.8 billion by 2030 and it is projected to grow at a CAGR of 35.8% from 2021 to 2030.

April 27, 2022
·
5 min read
Paragon 28 Launches Paratrooper™ Plantar Plate System for Hammertoe and Soft Tissue Repair

Paragon 28, Inc. announced today an expansion of its hammertoe and soft-tissue portfolio with the launch of its Paratrooper™ Plantar Plate Repair System.

April 27, 2022
·
2 min read
BioForest

Visus Therapeutics Announces New Scientific Data to Be Presented During the 2022 ARVO Annual Meeting

Visus Therapeutics Inc. today announced that it will present new scientific data at the 2022 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting , to be held May 1-4, 2022 in Denver, Colorado.

April 27, 2022
·
3 min read
BioMidwest

Truvian Sciences President and CEO Jeff Hawkins to Speak Among Leaders of Nation’s Most Innovative Labs at The Dark Intelligence Group’s Executive War College Conference

Truvian Sciences President and CEO Jeff Hawkins joins leaders of the nation’s most innovative labs to share new technologies and approaches to improve patient outcomes.

April 27, 2022
·
1 min read
Pharm Country

SCYNEXIS Presents Data Analyses Showing Ibrexafungerp’s Potential to Fight Invasive Candidiasis and Candidemia, Including Infections Caused by Candida Auris, During the 32nd Annual European Congress of Clinical Microbiology & Infectious Diseases

SCYNEXIS, Inc. announced several poster presentations highlighting details from interim analyses of data from its ongoing Phase 3 FURI and CARES studies investigating the potential of ibrexafungerp as a treatment for invasive candidiasis and candidemia, including infections caused by Candida auris.

April 27, 2022
·
6 min read
Business

Sarepta Therapeutics to Announce First Quarter 2022 Financial Results and Recent Corporate Developments on May 4, 2022

Sarepta Therapeutics, Inc. will report first quarter 2022 financial results after the Nasdaq Global Market closes on Wednesday, May 4, 2022.

April 27, 2022
·
1 min read
Pharm Country

Updated Guidance for COVID-19 Vaccination from NCCN Recommends Fifth mRNA Shot (Second Booster Dose) for Immunocompromised People

Today, the National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—released the latest recommendations from the NCCN Advisory Committee on COVID-19 Vaccination and Pre-exposure Prophylaxis.

April 27, 2022
·
4 min read
Guardian Research Network and Cytel Announce Presentation at ISPOR 2022 Detailing Covid-19’s Impact on Breast Cancer

Guardian Research Network, Inc. (GRN) and Cytel Inc. are pleased to announce an upcoming presentation at ISPOR 2022, Washington, DC. ISPOR is the leading professional society for health economics and outcomes research.

April 27, 2022
·
3 min read
Business

Arpa Garay Joins Moderna as Chief Commercial Officer

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, announced that Arpa Garay will join Moderna as Chief Commercial Officer, effective Monday, May 31, 2022.

April 27, 2022
·
5 min read